Discover the full insider trade history of 에이비프로바이오, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Market capitalisation: €74bn. The latest transaction was filed on 8 April 2026 — Purchase. Among the most active insiders: 리턴즈. The full history is accessible without an account.